Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives.

导出 OA

翻译打印收藏纠错

第一作者： Luca,Urso

第一单位： Department of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy.

作者： Luca,Urso ^[1] ; Angelo,Castello ^[2] ; Giovanni Christian,Rocca ^[3] ; Federica,Lancia ^[4] ; Stefano,Panareo ^[5] ; Corrado,Cittanti ^[6] ; Licia,Uccelli ^[7] ; Luigia,Florimonte ^[8] ; Massimo,Castellani ^[1] ; Carmelo,Ippolito ^[2] ; Antonio,Frassoldati ^[3] ; Mirco,Bartolomei ^[3]

作者单位： Department of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. ^[1] Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, Ferrara, Italy. ^[2] Department of Nuclear Medicine, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. ^[3] Urology Unit, Surgical Department, University Hospital of Ferrara, Ferrara, Italy. ^[4] Oncological Medical and Specialists Department, Oncology Unit, University Hospital of Ferrara, Ferrara, Italy. ^[5] Nuclear Medicine Unit, Oncology and Haematology Department, University Hospital of Modena, Modena, Italy. ^[6] Department of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. ctc@unife.it. ^[7] Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, Ferrara, Italy. ctc@unife.it. ^[8]

关键词 Clear cell Renal Cell Carcinoma PSMA PET/CT Positron emission tomography Prostate-specific membrane antigen Renal Cell Carcinoma Renal neoplasms